Alain Thibault - Profile and Investment Details

Investor Profile

Alain Thibault is a Venture Capital based in Munich, Bavaria, Germany with a diverse investment portfolio that includes companies such as AurKa Pharma, Centogene, CoLucid Pharmaceuticals, Emovi, AL-S Pharma, Acer Therapeutics, Kent Imaging, Panthera Dental inc, Access Vascular, Esperas Pharma, leon nanodrugs. Over time, Alain Thibault has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Alain Thibault is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Medical Testing, DentalTech, Product Design, Biotech, Medical Device, Manufacturing, Healthcare, Biotechnology, Genomics, Clinical Trials, Health Diagnostics, Medical, Therapeutics, Advanced Materials, Pharmaceuticals may find it worthwhile to explore potential connections with Alain Thibault, as their portfolio suggests a familiarity and interest in this area.

Understanding Alain Thibault’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.